In brain metastases, astrocyte-derived TIMP1 suppresses CD8+ T cell activity (60), while in pancreatic cancer, TIMP1-CD63-ERK signaling drives neutrophil extracellular trap formation and tumor progression (61). Here, TIMP1 is linked to neoplasm.